JPH1095733A5 - - Google Patents

Info

Publication number
JPH1095733A5
JPH1095733A5 JP1997178391A JP17839197A JPH1095733A5 JP H1095733 A5 JPH1095733 A5 JP H1095733A5 JP 1997178391 A JP1997178391 A JP 1997178391A JP 17839197 A JP17839197 A JP 17839197A JP H1095733 A5 JPH1095733 A5 JP H1095733A5
Authority
JP
Japan
Prior art keywords
acne
represent
formula
acceptable salt
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997178391A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1095733A (ja
JP4008534B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP17839197A priority Critical patent/JP4008534B2/ja
Priority claimed from JP17839197A external-priority patent/JP4008534B2/ja
Publication of JPH1095733A publication Critical patent/JPH1095733A/ja
Publication of JPH1095733A5 publication Critical patent/JPH1095733A5/ja
Application granted granted Critical
Publication of JP4008534B2 publication Critical patent/JP4008534B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP17839197A 1996-07-31 1997-07-03 にきび治療薬 Expired - Lifetime JP4008534B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17839197A JP4008534B2 (ja) 1996-07-31 1997-07-03 にきび治療薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-200900 1996-07-31
JP20090096 1996-07-31
JP17839197A JP4008534B2 (ja) 1996-07-31 1997-07-03 にきび治療薬

Publications (3)

Publication Number Publication Date
JPH1095733A JPH1095733A (ja) 1998-04-14
JPH1095733A5 true JPH1095733A5 (enExample) 2005-04-07
JP4008534B2 JP4008534B2 (ja) 2007-11-14

Family

ID=26498572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17839197A Expired - Lifetime JP4008534B2 (ja) 1996-07-31 1997-07-03 にきび治療薬

Country Status (1)

Country Link
JP (1) JP4008534B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2332808C (en) 1998-05-15 2010-11-23 Showa Denko K.K. Compositions of ascorbic acid derivatives for treatment of skin diseases
JP4828126B2 (ja) * 2005-02-03 2011-11-30 日本メナード化粧品株式会社 抗菌剤
JP2009143897A (ja) * 2007-11-19 2009-07-02 Neochemir Inc ニキビ治療剤
JP6311049B1 (ja) * 2016-11-25 2018-04-11 ロート製薬株式会社 背中用にきび予防及び／又は治療薬

Similar Documents

Publication Publication Date Title
JP2002511411A5 (enExample)
JP2003531118A5 (enExample)
CA2260337A1 (en) Therapeutic agents
WO2002062398A3 (en) Radioactively labelled conjugates of phosphonates
CY1112899T1 (el) Παραγωγα θειαδιαζολινης για τη θεραπεια του καρκινου
DE60012883D1 (de) 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepin-3-hydroxamsäure als matrix metalloproteinaseinhibitoren
CA2369947A1 (en) Hydroxamic acid derivative
PT1210349E (pt) Pirazolo-¬4,3-d|-pirimidinas
JP2005509503A5 (enExample)
RU97105811A (ru) Фуллереновое производное гликопептида, обладающее адъювантной активностью
RU96112258A (ru) Способ усиления солнцезащитной активности фотозащитных агентов
DE69907495D1 (de) (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on als reine verbindung
JPH1053941A5 (enExample)
JP2003514806A5 (enExample)
JP2002523361A5 (enExample)
RU98116380A (ru) Применение ингибиторов натрий-водородного обмена для получения лекарственного средства в целях лечения заболеваний, вызываемых простейшими
CO5021190A1 (es) Agentes terapeuticos
RU99127647A (ru) Средство для лечения сексуальных дисфункций у мужчин
AU1593101A (en) Animal models for cardiac disease
FR2718643B1 (fr) Hépato-dialyseur extra-corporel utilisant le foie prélevé d'un être vivant.
JP2000026982A5 (enExample)
JP2003012516A5 (enExample)
RU96113017A (ru) Средство, повышающее эффективность лечения туберкулеза
IT1310674B1 (it) Apparecchiatura di selezione d'assetto di un corpo per cerniere lampo.
JP2000017561A5 (enExample)